Evidence map›Paper›PMID 11704866›Full record

ArticleOncogene2001

Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.

A Sepehr, P Tanière, G Martel-Planche, A A Zia'ee, F Rastgar-Jazii, M Yazdanbod, G Etemad-Moghadam, F Kamangar, F Saidi, P Hainaut

Erratum issuedAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2019
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Esophageal cancer in kashmir (India): an enigma for researchers.International journal of health sciences · 2009
    Article
  15. Article
  16. Article
  17. Article
  18. Mutations of p53 gene exons 4-8 in human esophageal cancer.World journal of gastroenterology · 2005
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

A SepehrGroup of Molecular Carcinogenesis, International Agency for Research on Cancer (IARC), 150, cours Albert-Thomas, Lyon 69008, France.
P Tanière
G Martel-Planche
A A Zia'ee
F Rastgar-Jazii
M Yazdanbod
G Etemad-Moghadam
F Kamangar
F Saidi
P Hainaut
Centre International de Recherche sur le Cancer · FRBloomberg (United States) · USNational Cancer Institute · USNational Institute of Genetic Engineering and Biotechnology · IRTehran University of Medical Sciences · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extremely high rates of squamous cell carcinoma of the esophagus (SCCE) are observed in Iran, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic alterations in SCCE, TP53 mutations are the most frequent, vary among populations, and may provide clues on etiological mechanisms. We have analysed mutations in TP53 (exons 5-8) in 98 SCCE from Iran by temporal temperature gel electrophoresis and direct sequencing. We found 58 mutations in 49 patients (50%), with a high prevalence of C to T transitions at CpG dinucleotides (29.3%). The TP53 mutation pattern in Iran was significantly different from that observed in SCCEs from high incidence areas of China and Western Europe (P=0.007). Moreover, the prevalence of mutations at A : T base pairs (transitions and transversions) was higher in men than in women (38.7% vs 11.1%, P=0.033). COX-2 overexpression was detected in 69% of the cases evaluated (24/35), without significant association with TP53 mutation. Accumulation of nitrotyrosine, a marker of protein damage by excess levels of nitric oxide, was observed in tumor cells in six of 18 [corrected] cases analysed. These results are consistent with the hypothesis that several factors are involved in TP53 mutagenesis in Iran. These factors include a baseline of chronic inflammatory stress, which may have a multiplicative impact on the sensitivity of esophageal cells to exogenous factors of risk.

Indexed as

Genes, p53MutationAdultAgedAged, 80 and overCarcinoma, Squamous CellChinaChronic DiseaseCodonCodon, NonsenseCpG IslandsCyclooxygenase 2DNA Mutational AnalysisDNA, NeoplasmEsophageal NeoplasmsEsophagitis3-nitrotyrosineCodonCodon, NonsenseCyclooxygenase 2DNA, NeoplasmIsoenzymesMembrane ProteinsNeoplasm ProteinsNitric OxideProstaglandin-Endoperoxide SynthasesPTGS2 protein, humanTyrosine

Identifiers

PMID11704866
OpenAlexW2067782223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.